SPRO
#4037
Spero Therapeutics, Inc. - Common Stock
1.1 8 USD
-0.02%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-1.67%
Changement Mensuel
+4.42%
Evolution sur 6 mois
-58.45%
Changement Annuel
-47.32%
Clôture Précédente
1.2 0
Open
1.2 0
Low
1.1 7
High
1.2 2
Financials
- Market Capitalization 68.72 M
- Employee 25
- Founded 2013
- CEO Ankit Mahadevia
- Website www.sperotherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00HXSJ1R2
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
15.53
ratio cours/chiffre d'affaires
2.06
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4034 |  CSBR Champions Oncology, Inc. - Common Stock | 4.95 USD | -0.60% | +1.02% | -1.20% | -23.61% | 68.90 M USD | ||
| 4035 |  VRCA Verrica Pharmaceuticals Inc. - Common Stock | 4.01 USD | -2.43% | -8.03% | -18.33% | -33.39% | 68.89 M USD | ||
| 4040 |  GANX Gain Therapeutics, Inc. - Common Stock | 1.57 USD | -4.27% | -7.65% | -10.80% | -17.37% | 68.52 M USD | ||
| 4041 |  TENX Tenax Therapeutics, Inc. - Common Stock | 1.83 USD | -2.14% | -7.11% | -0.54% | -75.76% | 68.49 M USD |